Endothelial Cell Loss in Patients with Phakic Intraocular Lenses

Abstract

Although the safety of phakic intraocular lenses (pIOLs) has been continuously improved over 70-years of development, high endothelial cell losses can occur even with current pIOL models. Numerous studies have demonstrated that the distance of a pIOL to the corneal endothelium plays a crucial role in the extent of endothelial cell loss. For this reason alone, higher endothelial cell loss tends to be observed with anterior chamber lenses than with posterior chamber lenses. Adequate preoperative anterior chamber depth is essential, at least for iris-fixed pIOLs, in order to ensure a safe distance from the endothelium. However, the anterior chamber becomes shallower with age and therefore it may be useful to consider patient age in the safety criteria. Although endothelial cell loss is generally low with current pIOL models, regular monitoring of the endothelial cell density remains essential due to large interindividual differences in patients with pIOLs. If the endothelial cell loss is greater than expected and the follow-up visits confirm the trend, the pIOL should be explanted without delay. The endothelial reserve should be considered on an individual basis by taking into account patient age, physiological endothelial cell loss, and loss due to further surgery. With careful indication and long-term patient care, pIOLs remain a safe treatment option.

Key words

refractive surgery - phakic intraocular lenses - pIOL - endothelial cell loss - endothelium - cornea

Publication History

Received: 31 January 2023

Accepted: 06 November 2023

Article published online:
19 January 2024

• References/Literatur

• 1 Güell JL, Morral M, Kook D. et al. Phakic intraocular lenses part 1: historical overview, current models, selection criteria, and surgical techniques. J Cataract Refract Surg 2010; 36: 1976-1993 DOI: 10.1016/j.jcrs.2010.08.014.
• 2 Yildirim Y, Çakmak S, Sucu ME. et al. Comparative study of small-incision lenticule extraction and phakic intraocular lens implantation for the correction of high myopia: 6-year results. J Cataract Refract Surg 2021; 47: 221-226 DOI: 10.1097/j.jcrs.0000000000000418.
• 3 Sarver EJ, Sanders DR, Vukich JA. Image quality in myopic eyes corrected with laser in situ keratomileusis and phakic intraocular lens. J Refract Surg 2003; 19: 397-404 DOI: 10.3928/1081-597x-20030701-04.
• 4 Packer KT, Vlasov A, Greenburg DL. et al. U.S. military implantable collamer lens surgical outcomes: 11-year retrospective review. J Cataract Refract Surg 2022; 48: 649-656 DOI: 10.1097/j.jcrs.0000000000000818.
• 5 Auffarth GU, Apple DJ. [History of the development of intraocular lenses]. Ophthalmologe 2001; 98: 1017-1028 DOI: 10.1007/s003470170020.
• 6 Javaloy J, Alió JL, Iradier MT. et al. Outcomes of ZB5M angle-supported anterior chamber phakic intraocular lenses at 12 years. J Refract Surg 2007; 23: 147-158 DOI: 10.3928/1081-597x-20070201-07.
• 7 Martínez-Plaza E, López-Miguel A, Holgueras A. et al. Phakic intraocular lenses: Recent advances and innovations. Arch Soc Esp Oftalmol (Engl Ed) 2020; 95: 178-187 DOI: 10.1016/j.oftal.2020.02.001.
• 8 Plainer S, Wenzl E, Saalabian AA. et al. Long-term follow-up with I-CARE phakic IOLs. Br J Ophthalmol 2011; 95: 710-714 DOI: 10.1136/bjo.2009.172650.
• 9 Kohnen T, LaFontaine L, Andrew R. Long-term safety follow-up of an anterior chamber angle-supported phakic intraocular lens. J Cataract Refract Surg 2017; 43: 1163-1170 DOI: 10.1016/j.jcrs.2017.06.035.
• 10 Knorz MC, Lane SS, Holland SP. Angle-supported phakic intraocular lens for correction of moderate to high myopia: Three-year interim results in international multicenter studies. J Cataract Refract Surg 2011; 37: 469-480 DOI: 10.1016/j.jcrs.2010.09.025.
• 11 Kohnen T, Maxwell A, Holland S. et al. Ten-year safety follow-up and post-explant analysis of an anterior chamber phakic IOL. J Cataract Refract Surg 2020; 46: 1457-1465 DOI: 10.1097/j.jcrs.0000000000000351.
• 12 Worst JG, van der Veen G, Los LI. Refractive surgery for high myopia. The Worst-Fechner biconcave iris claw lens. Doc Ophthalmol 1990; 75: 335-341 DOI: 10.1007/bf00164848.
• 13 Güell JL, Morral M, Gris O. et al. Five-year follow-up of 399 phakic Artisan-Verisyse implantation for myopia, hyperopia, and/or astigmatism. Ophthalmology 2008; 115: 1002-1012 DOI: 10.1016/j.ophtha.2007.08.022.
• 14 Budo C, Hessloehl JC, Izak M. et al. Multicenter study of the Artisan phakic intraocular lens. J Cataract Refract Surg 2000; 26: 1163-1171 DOI: 10.1016/s0886-3350(00)00545-9.
• 15 Tehrani M, Dick HB. Iris-fixated toric phakic intraocular lens: Three-year follow-up. J Cataract Refract Surg 2006; 32: 1301-1306 DOI: 10.1016/j.jcrs.2006.02.058.
• 16 Benedetti S, Casamenti V, Benedetti M. Long-term endothelial changes in phakic eyes after Artisan intraocular lens implantation to correct myopia: five-year study. J Cataract Refract Surg 2007; 33: 784-790 DOI: 10.1016/j.jcrs.2007.01.037.
• 17 Tahzib NG, Nuijts RM, Wu WY. et al. Long-term study of Artisan phakic intraocular lens implantation for the correction of moderate to high myopia: ten-year follow-up results. Ophthalmology 2007; 114: 1133-1142 DOI: 10.1016/j.ophtha.2006.09.029.
• 18 Saxena R, Boekhoorn SS, Mulder PG. et al. Long-term follow-up of endothelial cell change after Artisan phakic intraocular lens implantation. Ophthalmology 2008; 115: 608-613.e1 DOI: 10.1016/j.ophtha.2007.05.036.
• 19 Bouheraoua N, Bonnet C, Labbé A. et al. Iris-fixated phakic intraocular lens implantation to correct myopia and a predictive model of endothelial cell loss. J Cataract Refract Surg 2015; 41: 2450-2457 DOI: 10.1016/j.jcrs.2015.05.030.
• 20 Qasem Q, Kirwan C, OʼKeefe M. 5-year prospective follow-up of Artisan phakic intraocular lenses for the correction of myopia, hyperopia and astigmatism. Ophthalmologica 2010; 224: 283-290 DOI: 10.1159/000299179.
• 21 Jonker SMR, Berendschot T, Ronden AE. et al. Long-Term Endothelial Cell Loss in Patients with Artisan Myopia and Artisan Toric Phakic Intraocular Lenses: 5- and 10-Year Results. Ophthalmology 2018; 125: 486-494 DOI: 10.1016/j.ophtha.2017.08.011.
• 22 Chebli S, Rabilloud M, Burillon C. et al. Corneal Endothelial Tolerance After Iris-Fixated Phakic Intraocular Lens Implantation: A Model to Predict Endothelial Cell Survival. Cornea 2018; 37: 591-595 DOI: 10.1097/ico.0000000000001527.
• 23 Morral M, Güell JL, El Husseiny MA. et al. Paired-eye comparison of corneal endothelial cell counts after unilateral iris-claw phakic intraocular lens implantation. J Cataract Refract Surg 2016; 42: 117-126 DOI: 10.1016/j.jcrs.2015.08.018.
• 24 Eldanasoury AM, Roozbahani M, Tolees S. et al. Long-Term Effect of Anterior Chamber Depth on Endothelial Cell Density in Patients With Iris-Fixated Phakic Intraocular Lenses. J Refract Surg 2019; 35: 493-500 DOI: 10.3928/1081597x-20190708-01.
• 25 Nemcova I, Pasta J, Hladikova K. et al. Myopic Correction with Iris-Fixated Phakic Intraocular Lenses: Twelve-Year Results. J Ophthalmol 2021; 2021: 7027793 DOI: 10.1155/2021/7027793.
• 26 Yaşa D, Ağca A. Verisyse versus Veriflex Phakic Intraocular Lenses: Refractive Outcomes and Endothelial Cell Density 5 Years after Surgery. J Ophthalmol 2018; 2018: 4210460 DOI: 10.1155/2018/4210460.
• 27 Bourne WM, Nelson LR, Hodge DO. Central corneal endothelial cell changes over a ten-year period. Invest Ophthalmol Vis Sci 1997; 38: 779-782
• 28 van Rijn GA, Gaurisankar ZS, Ilgenfritz AP. et al. Middle- and long-term results after iris-fixated phakic intraocular lens implantation in myopic and hyperopic patients: a meta-analysis. J Cataract Refract Surg 2020; 46: 125-137 DOI: 10.1097/j.jcrs.0000000000000002.
• 29 Muñoz G, Cardoner A, Albarrán-Diego C. et al. Iris-fixated toric phakic intraocular lens for myopic astigmatism. J Cataract Refract Surg 2012; 38: 1166-1175 DOI: 10.1016/j.jcrs.2012.02.034.
• 30 Marta A, Leite J, Abreu AC. et al. Long-term results in patients with iris-fixated foldable phakic intraocular lenses for myopia and astigmatism. J Cataract Refract Surg 2022; 48: 993-998 DOI: 10.1097/j.jcrs.0000000000000914.
• 31 Doors M, Cals DW, Berendschot TT. et al. Influence of anterior chamber morphometrics on endothelial cell changes after phakic intraocular lens implantation. J Cataract Refract Surg 2008; 34: 2110-2118 DOI: 10.1016/j.jcrs.2008.08.023.
• 32 Castro de Luna G, Ramos-López D, Castaño Fernández AB. et al. Artiflex foldable lens for myopia correction results of 10 years of follow-up. Eye (Lond) 2019; 33: 1564-1569 DOI: 10.1038/s41433-019-0446-7.
• 33 Jonker SMR, Berendschot T, Ronden AE. et al. Five-Year Endothelial Cell Loss After Implantation With Artiflex Myopia and Artiflex Toric Phakic Intraocular Lenses. Am J Ophthalmol 2018; 194: 110-119 DOI: 10.1016/j.ajo.2018.07.015.
• 34 Monteiro T, Correia FF, Franqueira N. et al. Long-term efficacy and safety results after iris-fixated foldable phakic intraocular lens for myopia and astigmatism: 6-year follow-up. J Cataract Refract Surg 2021; 47: 211-220 DOI: 10.1097/j.jcrs.0000000000000419.
• 35 Papa-Vettorazzi MR, Moura-Coelho N, Manero F. et al. Long-term efficacy and safety profiles of iris-fixated foldable anterior chamber phakic intraocular lens implantation in eyes with more than 10 years of follow-up. J Cataract Refract Surg 2022; 48: 987-992 DOI: 10.1097/j.jcrs.0000000000000937.
• 36 Royo M, Jiménez Á, Martínez-Alberquilla I. et al. Eight-year follow-up of Artiflex and Artiflex Toric phakic intraocular lens. Eur J Ophthalmol 2022; 32: 2051-2058 DOI: 10.1177/11206721211035617.
• 37 Coullet J, Guëll JL, Fournié P. et al. Iris-supported phakic lenses (rigid vs. foldable version) for treating moderately high myopia: randomized paired eye comparison. Am J Ophthalmol 2006; 142: 909-916 DOI: 10.1016/j.ajo.2006.07.021.
• 38 Kwitko S, Zambon GM, Marafon SB. Artisan and artiflex phakic intraocular lenses for high ametropia: long-term results. Arch ClinExp Ophthalmol 2021; 3: 39-46 DOI: 10.46439/ophthalmology.3.028.
• 39 Sanders DR, Vukich JA, Doney K. et al. U.S. Food and Drug Administration clinical trial of the Implantable Contact Lens for moderate to high myopia. Ophthalmology 2003; 110: 255-266 DOI: 10.1016/s0161-6420(02)01771-2.
• 40 Edelhauser HF, Sanders DR, Azar R. et al. Corneal endothelial assessment after ICL implantation. J Cataract Refract Surg 2004; 30: 576-583 DOI: 10.1016/j.jcrs.2003.09.047.
• 41 Pesando PM, Ghiringhello MP, Di Meglio G. et al. Posterior chamber phakic intraocular lens (ICL) for hyperopia: ten-year follow-up. J Cataract Refract Surg 2007; 33: 1579-1584 DOI: 10.1016/j.jcrs.2007.05.030.
• 42 Alfonso JF, Baamonde B, Fernández-Vega L. et al. Posterior chamber collagen copolymer phakic intraocular lenses to correct myopia: five-year follow-up. J Cataract Refract Surg 2011; 37: 873-880 DOI: 10.1016/j.jcrs.2010.11.040.
• 43 Alfonso JF, Fernández-Vega-Cueto L, Alfonso-Bartolozzi B. et al. Five-Year Follow-up of Correction of Myopia: Posterior Chamber Phakic Intraocular Lens With a Central Port Design. J Refract Surg 2019; 35: 169-176 DOI: 10.3928/1081597x-20190118-01.
• 44 Choi JH, Lim DH, Nam SW. et al. Ten-year clinical outcomes after implantation of a posterior chamber phakic intraocular lens for myopia. J Cataract Refract Surg 2019; 45: 1555-1561 DOI: 10.1016/j.jcrs.2019.06.015.
• 45 Fernández-Vega-Cueto L, Alfonso-Bartolozzi B, Lisa C. et al. Seven-year follow-up of posterior chamber phakic intraocular lens with central port design. Eye Vis (Lond) 2021; 8: 23 DOI: 10.1186/s40662-021-00247-1.
• 46 Guber I, Mouvet V, Bergin C. et al. Clinical Outcomes and Cataract Formation Rates in Eyes 10 Years After Posterior Phakic Lens Implantation for Myopia. JAMA Ophthalmol 2016; 134: 487-494 DOI: 10.1001/jamaophthalmol.2016.0078.
• 47 Moya T, Javaloy J, Montés-Micó R. et al. Implantable Collamer Lens for Myopia: Assessment 12 Years After Implantation. J Refract Surg 2015; 31: 548-556 DOI: 10.3928/1081597x-20150727-05.
• 48 Papa-Vettorazzi MR, Güell JL, Cruz-Rodriguez JB. et al. Long-term efficacy and safety profiles after posterior chamber phakic intraocular lens implantation in eyes with more than 10 years of follow-up. J Cataract Refract Surg 2022; 48: 813-818 DOI: 10.1097/j.jcrs.0000000000000848.
• 49 Igarashi A, Shimizu K, Kamiya K. Eight-year follow-up of posterior chamber phakic intraocular lens implantation for moderate to high myopia. Am J Ophthalmol 2014; 157: 532-539.e1 DOI: 10.1016/j.ajo.2013.11.006.
• 50 Lee J, Kim Y, Park S. et al. Long-term clinical results of posterior chamber phakic intraocular lens implantation to correct myopia. Clin Exp Ophthalmol 2016; 44: 481-487 DOI: 10.1111/ceo.12691.
• 51 Nakamura T, Isogai N, Kojima T. et al. Posterior Chamber Phakic Intraocular Lens Implantation for the Correction of Myopia and Myopic Astigmatism: A Retrospective 10-Year Follow-up Study. Am J Ophthalmol 2019; 206: 1-10 DOI: 10.1016/j.ajo.2019.04.024.
• 52 Monteiro T, Pinto C, Franqueira N. et al. Efficacy and Safety After Toric Posterior Chamber Implantable Collamer Lens and Toric Iris-Fixated Foldable Phakic Intraocular Lens for Myopic Astigmatism. J Refract Surg 2022; 38: 339-347 DOI: 10.3928/1081597x-20220406-01.
• 53 Ghoreishi M, Kashfi A, Peyman M. et al. Comparison of Toric Implantable Collamer Lens and Toric Artiflex Phakic IOLs in Terms of Visual Outcome: a Paired Contralateral Eye Study. Am J Ophthalmol 2020; 219: 186-194 DOI: 10.1016/j.ajo.2020.06.021.
• 54 Awadein A, Habib AE. ICL versus Veriflex phakic IOL for treatment of moderately high myopia: randomized paired-eye comparison. J Refract Surg 2013; 29: 445-452 DOI: 10.3928/1081597x-20130617-02.
• 55 Shaaban YM, Badran TAF. Three-Year Effect of Phakic Intraocular Lenses on the Corneal Endothelial Cell Density. Clin Ophthalmol 2020; 14: 149-155 DOI: 10.2147/opth.S236041.
• 56 Karimian F, Baradaran-Rafii A, Hashemian SJ. et al. Comparison of three phakic intraocular lenses for correction of myopia. J Ophthalmic Vis Res 2014; 9: 427-433 DOI: 10.4103/2008-322x.150805.
• 57 Taneri S, Dick HB. Initial clinical outcomes of two different phakic posterior chamber IOLs for the correction of myopia and myopic astigmatism. Graefes Arch Clin Exp Ophthalmol 2022; 260: 1763-1772 DOI: 10.1007/s00417-021-05465-w.
• 58 Polytech Domilens GmbH. IPCL: Das refraktive One-Step-Verfahren. Accessed June 28, 2023 at: https://www.polytech-domilens.de/app/uploads/2022/01/ipcl_arztbroschuere.pdf
• 59 Schmid R, Luedtke H. A novel concept of correcting presbyopia: first clinical results with a phakic diffractive intraocular lens. Clin Ophthalmol 2020; 14: 2011-2019 DOI: 10.2147/OPTH.S255613.
• 60 Brar S, Gautam M, Sute SS. et al. Visual and Refractive Outcomes With the Eyecryl Phakic Toric IOL Versus the Visian Toric Implantable Collamer Lens: Results of a 2-Year Prospective Comparative Study. J Refract Surg 2021; 37: 7-15 DOI: 10.3928/1081597x-20201013-04.
• 61 Kohnen T, Maxwell WA, Holland S. Correction of Moderate to High Myopia with a Foldable, Angle-Supported Phakic Intraocular Lens: Results from a 5-Year Open-Label Trial. Ophthalmology 2016; 123: 1027-1035 DOI: 10.1016/j.ophtha.2015.12.028.
• 62 Pop M, Payette Y. Initial results of endothelial cell counts after Artisan lens for phakic eyes: an evaluation of the United States Food and Drug Administration Ophtec Study. Ophthalmology 2004; 111: 309-317 DOI: 10.1016/j.ophtha.2003.05.025.
• 63 Luft N, Hirnschall N, Schuschitz S. et al. Comparison of 4 specular microscopes in healthy eyes and eyes with cornea guttata or corneal grafts. Cornea 2015; 34: 381-386 DOI: 10.1097/ico.0000000000000385.
• 64 MacRae S, Holladay JT, Hilmantel G. et al. Special Report: American Academy of Ophthalmology Task Force Recommendations for Specular Microscopy for Phakic Intraocular Lenses. Ophthalmology 2017; 124: 141-142 DOI: 10.1016/j.ophtha.2016.09.034.
• 65 Shajari M, Scheffel M, Koss MJ. et al. Dependency of endothelial cell loss on anterior chamber depth within first 4 years after implantation of iris-supported phakic intraocular lenses to treat high myopia. J Cataract Refract Surg 2016; 42: 1562-1569 DOI: 10.1016/j.jcrs.2016.08.027.
• 66 OPHTEC BV. Sicherheitsmitteilung (Field Safety Notice, FSN). Phake Intraokularlinsen Artisan und Artiflex (15.09.2021). Im Internet (Stand 16.01.2023): https://www.bfarm.de/SharedDocs/Kundeninfos/DE/11/2021/20671-21_kundeninfo_de.pdf?__blob=publicationFile
• 67 Niu L, Miao H, Han T. et al. Visual outcomes of Visian ICL implantation for high myopia in patients with shallow anterior chamber depth. BMC Ophthalmol 2019; 19: 121 DOI: 10.1186/s12886-019-1132-z.
• 68 Qian T, Du J, Ren R. et al. Vault-correlated efficacy and safety of Implantable Collamer Lens V4c implantation for myopia in patients with shallow anterior chamber depth. Ophthalmic Res 2023; DOI: 10.1159/000528616.
• 69 Yang W, Zhao J, Sun L. et al. Four-year observation of the changes in corneal endothelium cell density and correlated factors after Implantable Collamer Lens V4c implantation. Br J Ophthalmol 2021; 105: 625-630 DOI: 10.1136/bjophthalmol-2020-316144.
• 70 Kommission Refraktive Chirurgie (KRC). Bewertung und Qualitätssicherung refraktiv-chirurgischer Eingriffe durch die DOG und den BVA – KRC-Empfehlungen (06/2022). Im Internet (Stand: 15.01.2023): http://bva.dog/krc/qualit.pdf
• 71 Richdale K, Bullimore MA, Zadnik K. Lens thickness with age and accommodation by optical coherence tomography. Ophthalmic Physiol Opt 2008; 28: 441-447 DOI: 10.1111/j.1475-1313.2008.00594.x.
• 72 Tandogan T, Holzer MP, Choi CY. et al. Material Analysis of Spontaneously Subluxated Iris-Fixated Phakic Intraocular Lenses. J Refract Surg 2016; 32: 618-625 DOI: 10.3928/1081597x-20160601-01.
• 73 Packer M. Meta-analysis and review: effectiveness, safety, and central port design of the intraocular collamer lens. Clin Ophthalmol 2016; 10: 1059-1077 DOI: 10.2147/opth.S111620.
• 74 Di Y, Li Y, Luo Y. Prediction of Implantable Collamer Lens Vault Based on Preoperative Biometric Factors and Lens Parameters. J Refract Surg 2023; 39: 332-339 DOI: 10.3928/1081597x-20230207-03.
• 75 Cerpa Manito S, Sánchez Trancón A, Torrado Sierra O. et al. Biometric and ICL-related risk factors associated to sub-optimal vaults in eyes implanted with implantable collamer lenses. Eye Vis (Lond) 2021; 8: 26 DOI: 10.1186/s40662-021-00250-6.
• 76 Reinstein DZ, Lovisolo CF, Archer TJ. et al. Comparison of postoperative vault height predictability using white-to-white or sulcus diameter-based sizing for the visian implantable collamer lens. J Refract Surg 2013; 29: 30-35 DOI: 10.3928/1081597x-20121210-02.
• 77 Trancón AS, Manito SC, Sierra OT. et al. Determining vault size in implantable collamer lenses: preoperative anatomy and lens parameters. J Cataract Refract Surg 2020; 46: 728-736 DOI: 10.1097/j.jcrs.0000000000000146.
• 78 Reinstein DZ, Archer TJ, Vida RS. et al. New Sizing Parameters and Model for Predicting Postoperative Vault for the Implantable Collamer Lens Posterior Chamber Phakic Intraocular Lens. J Refract Surg 2022; 38: 272-279 DOI: 10.3928/1081597x-20220302-01.
• 79 Nakamura T, Isogai N, Kojima T. et al. Optimization of implantable collamer lens sizing based on swept-source anterior segment optical coherence tomography. J Cataract Refract Surg 2020; 46: 742-748 DOI: 10.1097/j.jcrs.0000000000000134.
• 80 Nakamura T, Nishida T, Isogai N. et al. Evaluation of implantable collamer lens sizing developed by reviewing the horizontal compression-vault coefficient. J Cataract Refract Surg 2023; 49: 525-530 DOI: 10.1097/j.jcrs.0000000000001140.
• 81 Gaurisankar ZS, van Rijn GA, Cheng YYY. et al. Two-year results after combined phacoemulsification and iris-fixated phakic intraocular lens removal. Graefes Arch Clin Exp Ophthalmol 2022; 260: 1367-1375 DOI: 10.1007/s00417-021-05442-3.
• 82 de Vries NE, Tahzib NG, Budo CJ. et al. Results of cataract surgery after implantation of an iris-fixated phakic intraocular lens. J Cataract Refract Surg 2009; 35: 121-126 DOI: 10.1016/j.jcrs.2008.10.012.
• 83 Vargas V, Marinho A, El Sayyad F. et al. Safety and visual outcomes following Iris-claw phakic intraocular lens bilensectomy. Eur J Ophthalmol 2021; 31: 1795-1801 DOI: 10.1177/1120672120944033.
• 84 Vargas V, Alió JL, Barraquer RI. et al. Safety and visual outcomes following posterior chamber phakic intraocular lens bilensectomy. Eye Vis (Lond) 2020; 7: 34 DOI: 10.1186/s40662-020-00200-8.
• 85 Yildirim TM, Auffarth GU, Son HS. et al. Dispersive viscosurgical devices demonstrate greater efficacy in protecting corneal endothelium in vitro. BMJ Open Ophthalmol 2019; 4: e000227 DOI: 10.1136/bmjophth-2018-000227.
• 86 Storr-Paulsen A, Nørregaard JC, Farik G. et al. The influence of viscoelastic substances on the corneal endothelial cell population during cataract surgery: a prospective study of cohesive and dispersive viscoelastics. Acta Ophthalmol Scand 2007; 85: 183-187 DOI: 10.1111/j.1600-0420.2006.00784.x.
• 87 Kim TY, Moon IH, Park SE. et al. Long-Term Follow-Up of Corneal Endothelial Cell Changes After Iris-Fixated Phakic Intraocular Lens Explantation. Cornea 2023; 42: 150-155 DOI: 10.1097/ico.0000000000003001.
• 88 Yildirim TM, Khoramnia R, Son HS. et al. Reasons for explantation of phakic intraocular lenses and associated perioperative complications: cross-sectional explant registry analysis. BMC Ophthalmol 2021; 21: 80 DOI: 10.1186/s12886-021-01847-0.
• 89 Alió JL, Toffaha BT, Peña-Garcia P. et al. Phakic intraocular lens explantation: causes in 240 cases. J Refract Surg 2015; 31: 30-35 DOI: 10.3928/1081597x-20141202-01.
• 90 [Anonymous] Corneal Endothelial Photography: Three-year Revision. American Academy of Ophthalmology. Ophthalmology 1997; 104: 1360-1365
• 91 Ventura AC, Wälti R, Böhnke M. Corneal thickness and endothelial density before and after cataract surgery. Br J Ophthalmol 2001; 85: 18-20 DOI: 10.1136/bjo.85.1.18.
• 92 Naujokaitis T, Auffarth GU, Łabuz G. et al. Diagnostic Techniques to Increase the Safety of Phakic Intraocular Lenses. Diagnostics (Basel) 2023; 13: 2503 DOI: 10.3390/diagnostics13152503.